Add like
Add dislike
Add to saved papers

Quantification of the physical properties of keloid and hypertrophic scars using the Vesmeter novel sensing device.

There is still no objective method or reliable device to measure and assess the physical properties of keloid and hypertrophic scars. Using the Vesmeter, we measured the physical properties of keloid and hypertrophic scars, and investigated how their physical properties changed during the process of clinical follow-up. We followed up 11 patients with keloid (n = 6) and hypertrophic (n = 5) scars for 4 months, and measured their physical properties three times over a 2-month period using the Vesmeter. Measurements included hardness, elasticity, penetration depth, relaxation time, viscosity and viscoelastic ratio. All physical properties were measured simultaneously while an indenter was pressed onto the lesion and digitalise the measured data by analysing the wave forms of the lesion's surface behaviour. Data collection was repeated three times for each measurement point, and the average of these three values was used. Overall hardness and viscosity decreased in nine patients, whereas penetration depth increased in nine. Relaxation time decreased in nine patients and elasticity increased in six. Vesmeter was considered to be an objective, convenient and comparatively reliable measuring device for the quantification of the physical properties of keloid and hypertrophic scars.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app